The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,425.00
Bid: 2,420.00
Ask: 2,430.00
Change: 30.00 (1.25%)
Spread: 10.00 (0.413%)
Open: 2,475.00
High: 2,475.00
Low: 2,380.00
Prev. Close: 2,395.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

12 Oct 2023 07:00

RNS Number : 8500P
Oxford Instruments PLC
12 October 2023
 
Oxford Instruments plc

Half Year Trading Update - 12 October 2023

 

This announcement contains inside information.

 

Robust overall demand and order book visibility. Full year trading anticipated towards the lower end of expectations

 

Oxford Instruments plc, a global provider of high technology products and services to many of the world's leading companies and scientific research communities, is today issuing a trading update for the half year ended 30 September 2023.

 

Our differentiated positions in key structural growth markets including advanced materials, life science, compound semiconductor, and quantum technology are continuing to generate positive results overall.

 

Revenue is ahead of the first half of last year, with particularly good growth in Research & Discovery. Growth in Materials & Characterisation has been tempered by some softness in higher margin segments. Orders for the first half of the financial year are expected to be slightly behind a strong comparator period (HY23: up 18.7%), with some timing delays to anticipated customer orders impacting the first half. However, we expect to report good order book growth for the half year, reflecting a positive book-to-bill of approximately 1.07.

 

A currency headwind and continued investment in infrastructure, operational capability and capacity means that adjusted operating profit1 for the first six months of the year will be broadly in line with last year. We anticipate that this will result in a slightly reduced margin for the half year.

 

While we remain mindful of the current macro-economic and political climate, our order book for the remainder of FY23/24 is strong and supported by a robust pipeline. Our operational improvement programme is expected to support an increase in production alongside our normal seasonal second half weighting. This provides good visibility for an expected improvement in trading, with full year trading towards the lower end of expectations.

 

Oxford Instruments' results for the half year ending 30 September 2023 will be released on 14 November 2023.

  

 

Notes:

 

1. Adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, and the mark-to-market revaluation of financial derivatives

2. Oxford Instruments compiled analyst forecast range for adjusted operating profit (year to 31 March 2024) is £78.6m to £84.3m, with consensus at £82.8m

  

Enquiries:

 

Oxford Instruments plc

Richard Tyson, Chief Executive

Gavin Hill, Chief Financial Officer

Julian Wais, Head of Investor Relations

Tel: 01865 393200

 

 

MHP

Tim Rowntree/Katie Hunt/Eleni Menikou

oxfordinstruments@mhpgroup.com

Tel: 020 3128 8100

 

- Ends -

 

Issued for and on behalf of Oxford Instruments plc

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and?supports high-technology products and systems which allow the world's leading companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level. The Group's products and services help its customers to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries across its key market segments: Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, Energy & Environment and Quantum Technology.?

 

Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to enable a greener, healthier, more connected advanced society. Founded in 1959 as the first technology business to be spun out from?Oxford?University, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG). Its customer-centric, market-focused strategy creates competitive advantage through understanding the technical and commercial challenges in markets with long-term structural growth drivers.

 

For more information, visit www.oxinst.com? 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKDBNFBDDCKD
Date   Source Headline
3rd Jun 202112:49 pmPRNTotal Voting Rights
11th May 20212:13 pmPRNDirector/PDMR Shareholding
22nd Apr 20219:50 amPRNDirector/PDMR Shareholding
6th Apr 20213:43 pmPRNHolding(s) in Company
26th Mar 20217:00 amRNSTrading Update
11th Mar 20215:05 pmPRNDirector/PDMR Shareholding
10th Mar 20219:12 amPRNHolding(s) in Company
4th Mar 20214:48 pmPRNHolding(s) in Company
11th Feb 20214:24 pmPRNHolding(s) in Company
11th Feb 20211:26 pmPRNDirector/PDMR Shareholding
4th Feb 20214:42 pmPRNHolding(s) in Company
27th Jan 20218:00 amPRNDirectorate Change
12th Jan 202110:56 amPRNDirector/PDMR Shareholding
7th Jan 20214:09 pmPRNTotal Voting Rights
7th Jan 20213:29 pmPRNBlocklisting - Interim Review
11th Dec 202011:27 amPRNDirector/PDMR Shareholding
3rd Dec 20201:22 pmPRNTotal Voting Rights
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
17th Nov 202010:51 amPRNDirector/PDMR Shareholding-2nd amendment
17th Nov 202010:35 amPRNDirector/PDMR Shareholding - amendment
17th Nov 20208:58 amPRNDirector/PDMR Shareholding
12th Nov 20203:04 pmPRNDirector/PDMR Shareholding
10th Nov 20207:00 amRNSHalf-year results
15th Oct 202010:20 amPRNHolding(s) in Company
14th Oct 20201:29 pmPRNDirector/PDMR Shareholding
8th Oct 20204:04 pmPRNTotal Voting Rights
24th Sep 202010:33 amPRNDirector/PDMR Shareholding
14th Sep 202012:52 pmPRNHolding(s) in Company
10th Sep 20204:31 pmPRNDirector/PDMR Shareholding
8th Sep 20202:58 pmPRNTotal Voting Rights
8th Sep 20202:48 pmPRNResult of AGM
8th Sep 20207:00 amRNSChairman’s AGM Statement 2020
7th Sep 202012:27 pmPRNHolding(s) in Company
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
26th Aug 202012:02 pmRNSPrice Monitoring Extension
25th Aug 202012:02 pmRNSPrice Monitoring Extension
20th Aug 202012:02 pmRNSPrice Monitoring Extension
19th Aug 202012:02 pmRNSPrice Monitoring Extension
18th Aug 202012:03 pmRNSPrice Monitoring Extension
11th Aug 202010:05 amPRNAdditional Listing
11th Aug 20209:51 amPRNDirector/PDMR Shareholding
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn
7th Aug 202012:02 pmRNSPrice Monitoring Extension
6th Aug 202012:07 pmRNSSecond Price Monitoring Extn
6th Aug 202012:02 pmRNSPrice Monitoring Extension
3rd Aug 202012:07 pmRNSSecond Price Monitoring Extn
3rd Aug 202012:02 pmRNSPrice Monitoring Extension
30th Jul 202012:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.